Interaction of synthetic progestagens with renal mineralocorticoid receptors.
Progesterone increases urinary sodium excretion at least in part by competition for renal mineralocorticoid receptors. In contrast, synthetic progestagens do not increase sodium excretion or even cause a slight sodium retention. We therefore compared the ability of progesterone and 12 progesterone like compounds to displace [3H]aldosterone from binding at cytoplasmic mineralocorticoid receptors in rat kidney. All synthetic progesteronelike steroids were less active than progesterone in competing with [3H]aldosterone for the receptor binding: progesterone 100%, 11 beta-OH progesterone 50%, 17 alpha OH-progesterone 24% and 16 alpha-methyl-progesterone 3%. Derivates of 17 alpha OH-progesterone (medrogestone 5%, dydrogestone 4%, medroxy progesterone-acetate 2% and chlormadinone-acetate 0.5%) were more potent than 19-nor-testosterone derivates: ethisterone 1%, norethisterone less than 1%, norethindrone less than 1%, norethyl-nodrel less than 1%, and ethynodiol-diacetate less than 1%. The decreased affinity of synthetic progestins for mineralocorticoid receptors explains in part the lack of natriuretic activity of these compounds.
D000450:Aldosterone / Q000378:metabolism; D000818:Animals; D003600:Cytosol / Q000378:metabolism; D004347:Drug Interactions; D007668:Kidney / Q000378:metabolism*; D008297:Male; D008901:Mineralocorticoids / Q000378:metabolism*; D009318:Natriuresis / Q000187:drug effects; D011374:Progesterone / Q000494:pharmacology*; D045167:Progesterone Congeners / Q000494:pharmacology*; D051381:Rats; D011987:Receptors, Steroid / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism
D008901:Mineralocorticoids; D045167:Progesterone Congeners; D011987:Receptors, Steroid; D000450:Aldosterone; D011374:Progesterone; D012964:Sodium